---
figid: PMC6162445__cells-07-00117-g003
figtitle: Mechanism of GPCR bias agonism involves insulin receptor activation
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC6162445
filename: cells-07-00117-g003.jpg
figlink: /pmc/articles/PMC6162445/figure/cells-07-00117-f003/
number: F3
caption: 'Mechanism of GPCR bias agonism involves insulin receptor activation. Bradykinin
  and angiotensin II form a complex with the neuromedin B receptor (NMBR), IRβ, and
  Neu-1. Bradykinin and angiotensin II preferentially lead to insulin-receptor signaling
  by first forming a complex with NMBR. This heterodimerization leads Gα, β, and γ
  to activate MMP-9. Upon activation, MMP-9 removes EBP, which in turn activates Neu-1.
  Crosstalk between these activated components leads to the phosphorylation and subsequent
  activation of insulin receptor substrate 1 (IRS1), initiating the phosphoinositide
  3-kinase-protein kinase B (PI3K–AKT) pathway, in addition to others, without insulin.
  Citation: Taken from Haxho et al. [] with permission, Cellular Signaling, Volume
  43, Issue 6, March 2018, Pages 71–84. 0898-6568/© 2017 Published by Elsevier Inc.,
  Open access under CC BY-NC-ND license. The article is an Open Access article that
  permits unrestricted noncommercial use, provided the original work be appropriately
  cited.'
papertitle: Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular
  Matrix Remodeling.
reftext: Bessi Qorri, et al. Cells. 2018 Sep;7(9):117.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9457602
figid_alias: PMC6162445__F3
figtype: Figure
redirect_from: /figures/PMC6162445__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6162445__cells-07-00117-g003.html
  '@type': Dataset
  description: 'Mechanism of GPCR bias agonism involves insulin receptor activation.
    Bradykinin and angiotensin II form a complex with the neuromedin B receptor (NMBR),
    IRβ, and Neu-1. Bradykinin and angiotensin II preferentially lead to insulin-receptor
    signaling by first forming a complex with NMBR. This heterodimerization leads
    Gα, β, and γ to activate MMP-9. Upon activation, MMP-9 removes EBP, which in turn
    activates Neu-1. Crosstalk between these activated components leads to the phosphorylation
    and subsequent activation of insulin receptor substrate 1 (IRS1), initiating the
    phosphoinositide 3-kinase-protein kinase B (PI3K–AKT) pathway, in addition to
    others, without insulin. Citation: Taken from Haxho et al. [] with permission,
    Cellular Signaling, Volume 43, Issue 6, March 2018, Pages 71–84. 0898-6568/© 2017
    Published by Elsevier Inc., Open access under CC BY-NC-ND license. The article
    is an Open Access article that permits unrestricted noncommercial use, provided
    the original work be appropriately cited.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT2
  - VPS51
  - NMBR
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - EBP
  - GLB1
  - SH3D19
  - MMP9
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTG1
  - GNAQ
  - IRS1
  - GNAO1
  - angpt2b
  - nmbr
  - atr
  - ebp
  - mmp9
  - irs1
  - Bradykinin
  - Ga
  - PPCADOOO
  - Ga GTP
  - P13K B
  - AT
---
